What age is permitted to take vascepa by new york medicaid?

What age does New York Medicaid allow for Vascepa (icosapent ethyl)?

New York Medicaid generally follows FDA labeling for coverage and age-based eligibility. Vascepa (icosapent ethyl) is approved for:

- Adults (18 years and older) with certain triglyceride levels to reduce the risk of cardiovascular events, in specific populations.
- No pediatric age indication is listed in FDA labeling for Vascepa, so Medicaid typically does not authorize it for children when there is no approved pediatric use.

Because Medicaid plans can apply prior authorization and program-specific rules, the exact coverage decision can still depend on the prescriber, diagnosis, and required documentation.

Does the minimum age differ by Medicaid plan or prior authorization?

It can. Even when a drug’s FDA label is adult-only, a Medicaid managed care plan or fee-for-service pharmacy benefit may still require prior authorization and may deny if:
- the patient is under the labeled age range, or
- the requested use doesn’t match an approved indication.

If you tell me the patient’s age and whether the request is for cardiovascular risk reduction or high triglycerides, I can help you map that to the labeled indications and what information Medicaid typically asks for.

Where can I verify Vascepa’s FDA age labeling quickly?

You can cross-check labeling details through DrugPatentWatch.com, which links to key regulatory and market information for branded drugs like Vascepa:
- DrugPatentWatch (Vascepa): https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/